IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Advanced Enzyme Technologies IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 411.49 Cr. The company is based in Mumbai and caters to Healthcare sector. Axis Capital , ICICI Securities are the merchant bankers of Advanced Enzyme Technologies IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 18th January 2016.
Advanced Enzyme Technologies IPO posted revenues of ₹ 294.63 Cr. and PAT of ₹ 78.43 Cr. in FY16 on annualised basis.
Revenue:
₹ 294.63 Cr.
EBITDA Margin:
47.21
% 
Net Worth: ₹ 278.72 Cr.
Market Capitalisation:
[●]
P/E:
25.00 times
P/BV: [●]
EV/EBITDA: 0.30 times
Financial results of Advanced Enzyme Technologies IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Mar-16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 451.65 | 418.09 | 408.27 | 396.34 | |
| Net Worth | 278.72 | 210.03 | 166.36 | 161.96 | |
| Total Debt | 68.38 | 77.64 | 126.60 | 150.40 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
294.63
294.63 |
224.26 | 240.48 | 224.11 | |
EBITDA
EBITDA on annualised basis |
139.09
139.09 |
92.00 | 104.78 | 93.24 | |
PAT
PAT on annualised basis |
78.43
78.43 |
50.10 | 20.08 | 49.21 | |
Advanced Enzyme Technologies IPO PAT Margin is 26.62 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Advanced Enzyme Technologies IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Mar-16 | FY15 | FY14 | FY13 |
|---|---|---|---|---|
| EBITDA Margin (%) | 47.21 | 41.02 | 43.57 | 41.60 |
| PAT Margin (%) | 26.62 | 22.34 | 8.35 | 21.96 |
| EPS (₹) | 36.03 | 23.01 | 9.23 | 23.10 |
| ROE (%) | 28.14 | 23.85 | 12.07 | 30.38 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 17.37 | 11.98 | 4.92 | 12.42 |
| Debt to Equity | 0.25 | 0.37 | 0.76 | 0.93 |
The market Capitalisation of Advanced Enzyme Technologies IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Advanced Enzyme Technologies IPO prospectus highlights an Return on Equity (ROE) of 28.14 % , Return on Assets (ROA) of 17.37 %, and an EBITDA Margin of 47.21 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Advanced Enzyme Technologies IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Advanced Enzyme Technologies IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Advanced Enzyme Technologies IPO has a Price-to-Earnings (PE) ratio of 25.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Advanced Enzyme Technologies IPO reported revenue of ₹ 78.44 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Advanced Enzyme Technologies IPO provide insights into sales growth, market demand, and business scalability.
Advanced Enzyme Technologies recorded an EBITDA of ₹ 139.09 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Advanced Enzyme Technologies Profit After Tax (PAT) is ₹ 78.43 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 294.63 Cr.
EBITDA Margin:
47.21
%
Net Worth: ₹ 278.72 Cr.
Market Capitalisation:
[●]
P/E:
25.00 times
P/BV: [●]
EV/EBITDA:
[●]
Advanced Enzyme Technologies operates in Healthcare and Research And Development Manufacturing And Marketing Of Healthcare Products. The Issue is listed on BSE,NSE in Aug, 2016. Advanced Enzyme Technologies IPO size was 411.49 with Issue price of 896.00 .
Merchant Banker(s) of Advanced Enzyme Technologies IPO: Axis Capital Limited , ICICI Securities Limited
Advanced Enzyme Technologies IPO subscription was 116.02 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Advanced Enzyme Technologies IPO listed at a listing price of 1178.30 against the offer price of 896.00.
The current market price of Advanced Enzyme Technologies is 324.45.
Why Us?
